Antioxidant Potential and Inhibition of Mitochondrial Permeability Transition Pore by Myricetin Reduces Aluminium Phosphide-Induced Cytotoxicity and Mitochondrial Impairments
Oxidative stress and mitochondrial dysfunction are involved in the mechanisms of cardiac toxicity induced by aluminum phosphide (AlP). AlP-induced cardiotoxicity leads to cardiomyocyte death, cardiomyopathy, cardiac dysfunction, and eventually severe heart failure and death. Importantly, protecting...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2021-11-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.719081/full |
| _version_ | 1818431228107292672 |
|---|---|
| author | Ahmad Salimi Ahmad Salimi Zhaleh Jamali Mohammad Shabani Mohammad Shabani |
| author_facet | Ahmad Salimi Ahmad Salimi Zhaleh Jamali Mohammad Shabani Mohammad Shabani |
| author_sort | Ahmad Salimi |
| collection | DOAJ |
| description | Oxidative stress and mitochondrial dysfunction are involved in the mechanisms of cardiac toxicity induced by aluminum phosphide (AlP). AlP-induced cardiotoxicity leads to cardiomyocyte death, cardiomyopathy, cardiac dysfunction, and eventually severe heart failure and death. Importantly, protecting cardiomyocytes from death resulting from AlP is vital for improving survival. It has been reported that flavonoids such as myricetin (Myr) act as modifiers of mitochondrial function and prevent mitochondrial damage resulting from many insults and subsequent cell dysfunction. In this study, the ameliorative effect of Myr, as an important antioxidant and mitochondrial protective agent, was investigated in cardiomyocytes and mitochondria isolated from rat heart against AlP-induced toxicity, oxidative stress, and mitochondrial dysfunction. Treatment of AlP (20 μg/ml) significantly increased cytotoxicity; reduced glutathione (GSH) depletion, cellular reactive oxygen species (ROS) formation, malondialdehyde (MDA) level, ATP depletion, caspase-3 activation, mitochondrial membrane potential (ΔΨm) collapse, and lysosomal dysfunction; and decreased the activities of superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GSH-Px) in intact cardiomyocytes. Also, treatment of AlP (20 μg/ml) significantly increased mitochondrial dysfunction and swelling in isolated mitochondria. Myr (80 µM) appeared to ameliorate AlP-induced cytotoxicity in isolated cardiomyocytes; significantly lessened the AlP-stimulated intracellular ROS and MDA production and depletion of GSH; and increased the activities of SOD, CAT, and GSH-Px. Furthermore, Myr (40 and 80 µM) lowered AlP-induced lysosomal/mitochondrial dysfunction, ATP depletion, and caspase-3 activation. In the light of these findings, we concluded that Myr through antioxidant potential and inhibition of mitochondrial permeability transition (MPT) pore exerted an ameliorative role in AlP-induced toxicity in isolated cardiomyocytes and mitochondria, and it would be valuable to examine its in vivo effects. |
| first_indexed | 2024-12-14T15:45:58Z |
| format | Article |
| id | doaj.art-da3ed911db2e449588889ef30de12881 |
| institution | Directory Open Access Journal |
| issn | 1663-9812 |
| language | English |
| last_indexed | 2024-12-14T15:45:58Z |
| publishDate | 2021-11-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Pharmacology |
| spelling | doaj.art-da3ed911db2e449588889ef30de128812022-12-21T22:55:30ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122021-11-011210.3389/fphar.2021.719081719081Antioxidant Potential and Inhibition of Mitochondrial Permeability Transition Pore by Myricetin Reduces Aluminium Phosphide-Induced Cytotoxicity and Mitochondrial ImpairmentsAhmad Salimi0Ahmad Salimi1Zhaleh Jamali2Mohammad Shabani3Mohammad Shabani4Department of Pharmacology and Toxicology, School of Pharmacy, Ardabil University of Medical Sciences, Ardabil, IranTraditional Medicine and Hydrotherapy Research Center, Ardabil University of Medical Sciences, Ardabil, IranStudent Research Committee, School of Medicine, Shahroud University of Medical Sciences, Shahroud, IranDepartment of Pharmacology and Toxicology, School of Pharmacy, Ardabil University of Medical Sciences, Ardabil, IranStudents Research Committee, School of Pharmacy, Ardabil University of Medical Sciences, Ardabil, IranOxidative stress and mitochondrial dysfunction are involved in the mechanisms of cardiac toxicity induced by aluminum phosphide (AlP). AlP-induced cardiotoxicity leads to cardiomyocyte death, cardiomyopathy, cardiac dysfunction, and eventually severe heart failure and death. Importantly, protecting cardiomyocytes from death resulting from AlP is vital for improving survival. It has been reported that flavonoids such as myricetin (Myr) act as modifiers of mitochondrial function and prevent mitochondrial damage resulting from many insults and subsequent cell dysfunction. In this study, the ameliorative effect of Myr, as an important antioxidant and mitochondrial protective agent, was investigated in cardiomyocytes and mitochondria isolated from rat heart against AlP-induced toxicity, oxidative stress, and mitochondrial dysfunction. Treatment of AlP (20 μg/ml) significantly increased cytotoxicity; reduced glutathione (GSH) depletion, cellular reactive oxygen species (ROS) formation, malondialdehyde (MDA) level, ATP depletion, caspase-3 activation, mitochondrial membrane potential (ΔΨm) collapse, and lysosomal dysfunction; and decreased the activities of superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GSH-Px) in intact cardiomyocytes. Also, treatment of AlP (20 μg/ml) significantly increased mitochondrial dysfunction and swelling in isolated mitochondria. Myr (80 µM) appeared to ameliorate AlP-induced cytotoxicity in isolated cardiomyocytes; significantly lessened the AlP-stimulated intracellular ROS and MDA production and depletion of GSH; and increased the activities of SOD, CAT, and GSH-Px. Furthermore, Myr (40 and 80 µM) lowered AlP-induced lysosomal/mitochondrial dysfunction, ATP depletion, and caspase-3 activation. In the light of these findings, we concluded that Myr through antioxidant potential and inhibition of mitochondrial permeability transition (MPT) pore exerted an ameliorative role in AlP-induced toxicity in isolated cardiomyocytes and mitochondria, and it would be valuable to examine its in vivo effects.https://www.frontiersin.org/articles/10.3389/fphar.2021.719081/fullcardiomyopathypoisoningflavonoidsantioxidantmitochondrial dysfunction |
| spellingShingle | Ahmad Salimi Ahmad Salimi Zhaleh Jamali Mohammad Shabani Mohammad Shabani Antioxidant Potential and Inhibition of Mitochondrial Permeability Transition Pore by Myricetin Reduces Aluminium Phosphide-Induced Cytotoxicity and Mitochondrial Impairments Frontiers in Pharmacology cardiomyopathy poisoning flavonoids antioxidant mitochondrial dysfunction |
| title | Antioxidant Potential and Inhibition of Mitochondrial Permeability Transition Pore by Myricetin Reduces Aluminium Phosphide-Induced Cytotoxicity and Mitochondrial Impairments |
| title_full | Antioxidant Potential and Inhibition of Mitochondrial Permeability Transition Pore by Myricetin Reduces Aluminium Phosphide-Induced Cytotoxicity and Mitochondrial Impairments |
| title_fullStr | Antioxidant Potential and Inhibition of Mitochondrial Permeability Transition Pore by Myricetin Reduces Aluminium Phosphide-Induced Cytotoxicity and Mitochondrial Impairments |
| title_full_unstemmed | Antioxidant Potential and Inhibition of Mitochondrial Permeability Transition Pore by Myricetin Reduces Aluminium Phosphide-Induced Cytotoxicity and Mitochondrial Impairments |
| title_short | Antioxidant Potential and Inhibition of Mitochondrial Permeability Transition Pore by Myricetin Reduces Aluminium Phosphide-Induced Cytotoxicity and Mitochondrial Impairments |
| title_sort | antioxidant potential and inhibition of mitochondrial permeability transition pore by myricetin reduces aluminium phosphide induced cytotoxicity and mitochondrial impairments |
| topic | cardiomyopathy poisoning flavonoids antioxidant mitochondrial dysfunction |
| url | https://www.frontiersin.org/articles/10.3389/fphar.2021.719081/full |
| work_keys_str_mv | AT ahmadsalimi antioxidantpotentialandinhibitionofmitochondrialpermeabilitytransitionporebymyricetinreducesaluminiumphosphideinducedcytotoxicityandmitochondrialimpairments AT ahmadsalimi antioxidantpotentialandinhibitionofmitochondrialpermeabilitytransitionporebymyricetinreducesaluminiumphosphideinducedcytotoxicityandmitochondrialimpairments AT zhalehjamali antioxidantpotentialandinhibitionofmitochondrialpermeabilitytransitionporebymyricetinreducesaluminiumphosphideinducedcytotoxicityandmitochondrialimpairments AT mohammadshabani antioxidantpotentialandinhibitionofmitochondrialpermeabilitytransitionporebymyricetinreducesaluminiumphosphideinducedcytotoxicityandmitochondrialimpairments AT mohammadshabani antioxidantpotentialandinhibitionofmitochondrialpermeabilitytransitionporebymyricetinreducesaluminiumphosphideinducedcytotoxicityandmitochondrialimpairments |